公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.
公司地址 9715 Key West Avenue, Rockville, MD, USA, 20850
電話號碼 +1 301 838-2500
傳真號碼 --
公司網頁 https://www.supernus.com
員工數量 778
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Frank Mottola Senior Vice President, Quality, GMP Operations and IT 美元 378.43K 24/02/2026
Mr. Padmanabh P. Bhatt Senior Vice President, Intellectual Property and Chief Scientific Officer 美元 441.03K 30/04/2025
Dr. Jonathan Rubin, M.B.A.,M.D. Senior Vice President and Chief Medical Officer, Research and Development 美元 467.50K 30/04/2025
Mr. Jack A. Khattar Director, President, Chief Executive Officer and Secretary 美元 1.01M 02/03/2026
Mr. Timothy C. Dec Senior Vice President, Principal Accounting Officer and Chief Financial Officer 美元 486.82K 02/03/2026
 
董事會成員
董事會 職務 更新日期
Mr. Frederick M. Hudson Independent Director 02/03/2026
Dr. Carrolee Barlow, M.D.,PhD Independent Director 02/03/2026
Mr. Jack A. Khattar Director, President, Chief Executive Officer and Secretary 02/03/2026
Dr. Georges Gemayel,PhD Independent Director 02/03/2026
Mr. Charles W. Newhall, III Chairman of the Board 02/03/2026
Ms. Bethany L. Sensenig Independent Director 02/03/2026
 
所屬ETF (更新日期: 07/03/2026 03:37)
代號 名稱 佔比% 持有日期
SMLFiShares U.S. Small-Cap Eq Fac ETF0.04%28/02/2026
GSCGoldman Sachs Small Cap Equity ETF0.04%27/02/2026
PSILAdvisorShares Psychedelics ETF0.03%27/02/2026
ONEQFidelity Nasdaq Composite ETF0.03%27/02/2026
BBSCJPMorgan BetaBuilders US Sml Cp Eq ETF0.03%27/02/2026
AVUSAvantis US Equity ETF0.03%28/02/2026
VFMFVanguard US Multifactor ETF0.03%31/12/2025
SIXLETC 6 Meridian Low Beta Eq Strat ETF0.03%27/02/2026
DFUSDimensional US Equity Market ETF0.03%27/02/2026
RWJInvesco S&P SmallCap 600 Revenue ETF0.03%27/02/2026
SMIZZacks Small/Mid Cap ETF0.03%27/02/2026
DFAUDimensional US Core Equity Market ETF0.02%27/02/2026
IWViShares Russell 3000 ETF0.02%28/02/2026
VFMOVanguard US Momentum Factor ETF0.02%31/12/2025
TPSCTimothy Plan US Small Cap Core ETF0.02%27/02/2026
ESGVVanguard ESG US Stock ETF0.02%31/01/2026
SMLVState Street® SPDR® USSmCapLowVolIndETF0.02%27/02/2026
DFSVDimensional US Small Cap Value ETF0.02%27/02/2026
SPTMState StreetSPDRPortS&P1500CompStkMktETF0.02%27/02/2026
ROSCHartford Multifactor Small Cap ETF0.02%28/02/2026
  1    2   3    4    5    6    7  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.